Recombinant Viola biflora Cyclotide vibi-H

Shipped with Ice Packs
In Stock

Description

Production and Purification

vibi-H is synthesized via recombinant DNA technology, leveraging yeast expression systems for scalable production. Post-expression steps include:

  1. Solubilization: Protein refolded in reducing agents to ensure proper disulfide bond formation.

  2. Purification: Chromatographic methods (e.g., RP-HPLC) to achieve >85% purity .

  3. Storage: Lyophilized or stored at -20°C/-80°C in glycerol-containing buffers to prevent degradation .

Biological Significance and Related Cyclotides

Cyclotides from Viola biflora are divided into Möbius (e.g., vibi-D) and bracelet (e.g., vibi-E, -G, -H) subfamilies, differing in cis-Pro bonds and surface charge. Bracelet cyclotides often exhibit higher cytotoxicity and antiviral activity due to hydrophobic regions interacting with membranes .

Key Findings from Viola biflora Cyclotides

PeptideSubfamilyIC50 (Cytotoxicity)Notable Activity
vibi-EBracelet0.96 μMLymphoma cell cytotoxicity
vibi-GBracelet1.2 μMMembrane disruption
vibi-HNot reportedNot reportedHypothesized similar activity

While vibi-H’s specific bioactivity remains unstudied, its structural homology to bracelet cyclotides suggests potential applications in antiviral or anticancer research .

Product Specs

Form
Lyophilized powder. We will ship the available format, but please specify any format requirements when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specifics. All proteins ship with blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
Cyclotide vibi-H
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-31
Protein Length
Cytoplasmic domain
Purity
>85% (SDS-PAGE)
Species
Viola biflora (Yellow wood violet)
Target Protein Sequence
GLLPCAESCV YIPCLTTVIG CSCKSKVCYK N
Uniprot No.

Target Background

Function
Likely involved in plant defense. Exhibits cytotoxic activity against a human lymphoma cell line with an IC50 of 1.6 µM.
Protein Families
Cyclotide family, Bracelet subfamily

Q&A

What is cyclotide vibi-H from Viola biflora?

Vibi-H is one of eleven cyclotides (vibi A-K) identified in the alpine violet Viola biflora, belonging to the bracelet subfamily of cyclotides. These head-to-tail cyclic proteins consist of approximately 30 amino acid residues with a complex structure featuring both a circular peptide backbone and a cystine knot, collectively forming the cyclic cystine knot (CCK) motif . This distinctive structure confers exceptional stability against thermal, chemical, and enzymatic degradation. Vibi-H specifically demonstrates significant cytotoxic activity against lymphoma cell lines with an IC50 value between 0.96 and 5.0 μM, making it particularly interesting for biomedical research .

How does the structure of vibi-H compare to other cyclotides from Viola biflora?

Vibi-H is classified as a bracelet cyclotide, which represents one of the two main subfamilies of cyclotides. A comparative analysis of structural characteristics reveals:

CyclotideSubfamilyKey Structural FeaturesBiological Activities
vibi-DMöbiusContains cis-Pro peptide bond in loop 5Not cytotoxic at 30 μM
vibi-EBraceletAll-trans peptide bondsCytotoxic (IC50: 0.96-5.0 μM)
vibi-GBraceletAll-trans peptide bondsCytotoxic (IC50: 0.96-5.0 μM)
vibi-HBraceletAll-trans peptide bondsCytotoxic (IC50: 0.96-5.0 μM)

The bracelet cyclotides from Viola biflora share structural similarities in their cyclic backbone and disulfide bonding pattern, but differ in their amino acid sequences, which accounts for their varying biological activities . This structural classification has significant implications for recombinant expression strategies and potential applications.

What are the key challenges in expressing recombinant cyclotides?

Expressing recombinant cyclotides presents several challenges due to their unique structural features:

  • Achieving correct folding of the cyclic cystine knot motif

  • Ensuring proper disulfide bond formation between the six conserved cysteine residues

  • Facilitating the head-to-tail cyclization of the peptide backbone

  • Maintaining solubility during expression and purification

  • Preventing degradation by host proteases

For vibi-H specifically, the bracelet cyclotide structure presents additional complexity in ensuring proper folding without the formation of cis-peptide bonds that characterize the Möbius subfamily . These challenges necessitate careful optimization of expression systems and conditions to produce functionally equivalent recombinant cyclotides.

What expression systems are suitable for recombinant cyclotide production?

Several expression systems have been investigated for recombinant cyclotide production, each with specific advantages and limitations:

  • Bacterial systems (E. coli): Cost-effective but often require refolding from inclusion bodies and additional cyclization steps

  • Yeast systems (P. pastoris): Better for disulfide bond formation but potential glycosylation issues

  • Plant cell cultures: Natural environment for cyclotide production but typically lower yields

  • Cell-free systems: Allow precise control but are more expensive

For vibi-H, the selection of an appropriate expression system depends on research objectives, prioritizing either yield, correct folding, or purification ease. The natural processing machinery in plant-based systems may be advantageous for achieving correct cyclization, but bacterial systems offer scalability advantages if proper refolding protocols are established .

How is the cyclic structure of vibi-H formed during recombinant expression?

The formation of the cyclic structure in recombinant cyclotides can be achieved through several approaches:

  • Intein-based methods: Using modified inteins that catalyze head-to-tail cyclization

  • Sortase-mediated ligation: Enzymatic approach using sortase to catalyze transpeptidation

  • Chemical ligation techniques: Solid-phase synthesis followed by chemical cyclization

  • Recombinant expression with cyclization domains: Engineering precursors with domains that facilitate self-cyclization

For vibi-H, understanding the natural cyclization mechanisms is crucial. In plants, cyclotides are expressed as precursor proteins that undergo processing by asparaginyl endopeptidases to achieve cyclization . Mimicking these natural processes or developing alternative strategies is essential for successful recombinant production.

What role do cyclotide precursor sequences play in recombinant expression?

Understanding cyclotide precursor sequences is crucial for designing effective recombinant expression strategies. In Viola species, cyclotides are naturally expressed as larger precursor proteins that undergo post-translational processing to yield mature cyclic peptides. These precursors typically contain:

  • An N-terminal signal sequence directing the protein to the endoplasmic reticulum

  • An N-terminal pro-region (N-terminal repeat, NTR)

  • The mature cyclotide domain

  • A C-terminal tail sequence

For Viola biflora cyclotides, researchers identified a conserved (AAFALPA) motif in the cyclotide precursor ER signal sequence, which was used for cDNA library screening to identify cyclotide genes . In recombinant expression systems, incorporating these natural precursor elements can improve folding and cyclization efficiency, though alternative approaches may be developed to bypass complex post-translational processing requirements.

How do recombinant and native vibi-H compare in terms of structural integrity and biological activity?

Comparing recombinant and native vibi-H is crucial for validating production methods. Key comparison aspects include:

  • Structural analysis: Using techniques like circular dichroism (CD), nuclear magnetic resonance (NMR), and mass spectrometry to confirm identical folding and disulfide bond patterns

  • Biological activity assays: Testing cytotoxicity against lymphoma cell lines to verify that recombinant vibi-H maintains the IC50 value between 0.96 and 5.0 μM observed in native vibi-H

  • Thermal and chemical stability profiles: Ensuring recombinant vibi-H retains the exceptional stability characteristic of natural cyclotides

  • Membrane interaction studies: Analyzing membrane-disrupting capabilities often associated with cyclotides' biological activities

Any discrepancies between native and recombinant forms would need to be addressed through optimization of expression and purification protocols. The high stability of the CCK motif makes it particularly important to verify correct disulfide bond formation in recombinant systems.

What are the optimal conditions for high-yield recombinant vibi-H expression?

Optimizing expression conditions for recombinant vibi-H involves systematically evaluating multiple parameters:

  • Temperature: Lower temperatures (16-25°C) often favor proper folding over rapid expression

  • Induction conditions: Concentration of inducer and timing of induction

  • Media composition: Enriched media for higher biomass versus defined media for consistency

  • Oxygen levels: Particularly important for proper disulfide bond formation

  • pH and ionic strength: Affecting protein solubility and stability

  • Co-expression with chaperones: To assist proper folding of the complex structure

  • Post-translational modifications: Ensuring any necessary modifications are properly executed

Experimental design typically involves factorial experiments to identify the optimal combination of conditions for maximum yield of correctly folded vibi-H. The cytotoxic nature of the product may also necessitate strategies to mitigate potential toxicity to the expression host.

How can site-directed mutagenesis be applied to enhance specific properties of vibi-H?

Site-directed mutagenesis offers powerful tools for modifying vibi-H properties:

  • Enhancing cytotoxicity: By modifying residues that interact with cell membranes

  • Improving selectivity: By introducing residues that target specific cell types

  • Modulating stability: By reinforcing or modifying the cyclic cystine knot scaffold

  • Creating fusion variants: By integrating functional domains while maintaining the cyclotide framework

  • Introducing non-natural amino acids: For specialized functions or improved pharmacokinetic properties

The conserved cysteine residues forming the cystine knot should generally be preserved to maintain core structural integrity, while modifications to other regions can be more extensively explored. Understanding the structure-activity relationship between vibi-H and other bracelet cyclotides provides guidance for rational design approaches .

What analytical methods are most effective for characterizing recombinant vibi-H?

Comprehensive characterization of recombinant vibi-H requires multiple complementary techniques:

  • Mass spectrometry (MS/MS): For sequence confirmation and detection of post-translational modifications, similar to methods used to characterize natural vibi-H

  • Nuclear magnetic resonance (NMR): For detailed 3D structural analysis

  • Circular dichroism (CD): For secondary structure assessment

  • Size-exclusion chromatography (SEC): For purity and aggregation analysis

  • Surface plasmon resonance (SPR): For binding kinetics with potential targets

  • Thermal shift assays: For stability assessment

  • Cytotoxicity assays: For functional characterization using lymphoma cell lines as described for native vibi-H

A combination of these methods provides a complete picture of the recombinant protein's structural and functional properties, ensuring its equivalence to the natural form.

How does the cytotoxic activity of vibi-H compare with other cyclotides from Viola biflora?

Based on research data, a comparative analysis of cytotoxicity shows:

CyclotideClassificationIC50 Value (μM)Notable Characteristics
vibi-DMöbius>30Not cytotoxic at tested concentrations
vibi-EBracelet0.96-5.0Potent cytotoxicity
vibi-GBracelet0.96-5.0Potent cytotoxicity
vibi-HBracelet0.96-5.0Potent cytotoxicity

This comparison demonstrates a clear structure-activity relationship, with bracelet cyclotides exhibiting significantly higher cytotoxicity than the Möbius variant . Understanding the molecular basis for these differences provides valuable insights for designing recombinant variants with specific cytotoxic properties.

What are the mechanistic details of vibi-H's membrane-disrupting activity?

The membrane-disrupting activity of bracelet cyclotides like vibi-H likely involves several mechanisms:

  • Electrostatic interactions between charged residues and membrane phospholipids

  • Hydrophobic residues inserting into the lipid bilayer

  • Formation of pores or channels disrupting membrane integrity

  • Potential clustering of specific membrane components leading to membrane destabilization

  • Possible interaction with intracellular targets after internalization

Experimental approaches to elucidate these mechanisms include liposome leakage assays, atomic force microscopy of treated membranes, and fluorescence microscopy to track membrane integrity in real-time. The cytotoxic activity of vibi-H against lymphoma cell lines (IC50 between 0.96 and 5.0 μM) suggests potent membrane-disrupting capabilities that could be harnessed for therapeutic applications .

How can recombinant vibi-H be used as a scaffold for developing peptide-based therapeutics?

Recombinant vibi-H offers several advantages as a scaffold for therapeutic development:

  • Exceptional stability against proteolytic degradation due to its cyclic cystine knot structure

  • Ability to tolerate sequence modifications in certain regions without compromising structural integrity

  • Natural membrane-penetrating properties that could facilitate drug delivery

  • Potential to incorporate bioactive peptide sequences within the cyclotide framework

  • Possibility of oral bioavailability, unlike most peptide therapeutics

Development strategies would involve identifying regions of vibi-H that can be modified without disrupting the core structure, then engineering variants carrying therapeutic peptide sequences or targeting moieties. The demonstrated cytotoxic activity suggests potential applications in cancer therapeutics, while the stable scaffold could enable development of peptide drugs for previously challenging targets .

How does vibi-H fit into the evolutionary framework of cyclotides?

Evolutionary analysis of cyclotides provides valuable context for understanding vibi-H and its properties:

  • Cyclotides have evolved as defense molecules in plants, primarily found in the Rubiaceae, Violaceae, and Cucurbitaceae families

  • Within the Violaceae family, the genus Viola has particularly high cyclotide diversity

  • Phylogenetic studies suggest that cyclotide genes underwent expansion and diversification during the evolution of these plant families

  • Cyclotide diversity in Viola species appears to be influenced by their ploidy level, with allopolyploid species showing greater cyclotide sequence diversity

  • Transcriptomic analysis across Viola species has revealed patterns of cyclotide expression that correlate with evolutionary relationships

Understanding vibi-H's evolutionary context can provide insights into its natural biological role and how it compares to cyclotides from other species or families. This knowledge can guide discovery of new cyclotides with desired properties by informing selection of plant species for investigation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.